Literature DB >> 27557816

Hsp90 inhibitor reduces porcine circovirus 2 replication in the porcine monocytic line 3D4/31.

Jie Liu1, Xuliang Zhang1, Chang Ma1, Ping Jiang2, Shifeng Yun3.   

Abstract

Porcine circovirus 2 (PCV2) is an important pathogen of swine, which causes porcine circovirus disease and porcine circovirus-associated diseases (PCVD/PCVAD). However, no effective countermeasures exist to combat this virus infection so far. Recently, heat shock protein 90 (Hsp90) was found to be an important host factor for the replication of multiple viruses and the inhibition of Hsp90 showed significant antiviral effects. Inhibition of Hsp90 by treatment of porcine monocytic line 3D4/31 with geldanamycin (GA), a specific inhibitor of Hsp90, caused a 70 % decrease in viral Cap protein expression. Further, individual knockdown targeting Hsp90α or Hsp90β with siRNAs resulted in down to 20-25 % of decrease in viral replication, and inhibited the PCV2 titer by approximately 12- and 15-fold, respectively. In addition, we investigated alteration of several cytokine production in PCV2-infected cells following treatment with GA. Then, we found that GA could decrease IL-1β, IL-6, and IL-12p40 mRNA levels, respectively, by 30, 40, and 40 % in PCV2-infected cells. Our results shed light on the possibility of developing potential therapeutics targeting Hsp90 against PCV2 infection.

Entities:  

Keywords:  Antiviral; Geldanamycin; Hsp90; Porcine circovirus type 2

Mesh:

Substances:

Year:  2016        PMID: 27557816     DOI: 10.1007/s11262-016-1385-z

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  37 in total

1.  Identification of Hsp90 as a stimulatory host factor involved in influenza virus RNA synthesis.

Authors:  Fumitaka Momose; Tadasuke Naito; Keiichi Yano; Seiji Sugimoto; Yuko Morikawa; Kyosuke Nagata
Journal:  J Biol Chem       Date:  2002-09-10       Impact factor: 5.157

2.  Identification of a protein essential for replication of porcine circovirus.

Authors:  A Mankertz; J Mankertz; K Wolf; H J Buhk
Journal:  J Gen Virol       Date:  1998-02       Impact factor: 3.891

Review 3.  Heat-shock protein 90, a chaperone for folding and regulation.

Authors:  D Picard
Journal:  Cell Mol Life Sci       Date:  2002-10       Impact factor: 9.261

4.  Cytokine induction by immunostimulatory DNA in porcine PBMC is impaired by a hairpin forming sequence motif from the genome of Porcine Circovirus type 2 (PCV2).

Authors:  F Hasslung Wikström; C Fossum; L Fuxler; R Kruse; T Lövgren
Journal:  Vet Immunol Immunopathol       Date:  2010-10-07       Impact factor: 2.046

Review 5.  Porcine circoviruses: a review.

Authors:  G M Allan; J A Ellis
Journal:  J Vet Diagn Invest       Date:  2000-01       Impact factor: 1.279

6.  Geldanamycin inhibits the production of inflammatory cytokines in activated macrophages by reducing the stability and translation of cytokine transcripts.

Authors:  Stephen Wax; Monica Piecyk; Beatrice Maritim; Paul Anderson
Journal:  Arthritis Rheum       Date:  2003-02

Review 7.  The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review.

Authors:  P Csermely; T Schnaider; C Soti; Z Prohászka; G Nardai
Journal:  Pharmacol Ther       Date:  1998-08       Impact factor: 12.310

8.  Vaccinia virus infection induces a stress response that leads to association of Hsp70 with viral proteins.

Authors:  S Jindal; R A Young
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

9.  Heat shock protein 90 controls HIV-1 reactivation from latency.

Authors:  Ian Anderson; Jun Siong Low; Stuart Weston; Michael Weinberger; Alexander Zhyvoloup; Aksana A Labokha; Gianmarco Corazza; Russell A Kitson; Christopher J Moody; Alessandro Marcello; Ariberto Fassati
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-31       Impact factor: 11.205

10.  A novel inhibitor of human La protein with anti-HBV activity discovered by structure-based virtual screening and in vitro evaluation.

Authors:  Jing Tang; Zhi-Min Huang; Ying-Yi Chen; Zhao-Hui Zhang; Gao-Lin Liu; Jian Zhang
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.